Daniel A Carestio, the President and CEO of $STE, sold 159 shares of the company on 10-06-2025 for an estimated $38,449. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.3% of their shares of this class of stock. Following this trade, they now own 51,096 shares of this class of $STE stock.
$STE Insider Trading Activity
$STE insiders have traded $STE stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $STE stock by insiders over the last 6 months:
- DANIEL A CARESTIO (President and CEO) has made 0 purchases and 4 sales selling 17,785 shares for an estimated $4,313,787.
- CARY L MAJORS (SVP and President, Healthcare) has made 0 purchases and 2 sales selling 12,828 shares for an estimated $3,208,025.
- KAREN L BURTON (VP & CAO) sold 7,900 shares for an estimated $1,909,667
- MOHSEN SOHI sold 4,110 shares for an estimated $994,455
- CYNTHIA L FELDMANN sold 3,495 shares for an estimated $844,252
- RENATO TAMARO (V.P. & Corporate Treasurer) sold 3,204 shares for an estimated $798,564
- JOHN ADAM ZANGERLE (Sr. VP, Gen Counsel, and Sec.) has made 0 purchases and 2 sales selling 1,978 shares for an estimated $477,581.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$STE Hedge Fund Activity
We have seen 441 institutional investors add shares of $STE stock to their portfolio, and 316 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WCM INVESTMENT MANAGEMENT, LLC removed 2,405,472 shares (-53.4%) from their portfolio in Q2 2025, for an estimated $577,842,483
- BLACKROCK, INC. removed 568,172 shares (-6.2%) from their portfolio in Q2 2025, for an estimated $136,486,277
- ORBIS ALLAN GRAY LTD added 556,088 shares (+36.0%) to their portfolio in Q2 2025, for an estimated $133,583,459
- JPMORGAN CHASE & CO removed 368,481 shares (-35.3%) from their portfolio in Q2 2025, for an estimated $88,516,505
- INVESCO LTD. added 297,076 shares (+32.2%) to their portfolio in Q2 2025, for an estimated $71,363,596
- GOLDMAN SACHS GROUP INC added 276,694 shares (+114.0%) to their portfolio in Q2 2025, for an estimated $66,467,432
- ASSENAGON ASSET MANAGEMENT S.A. added 249,386 shares (+305.9%) to their portfolio in Q3 2025, for an estimated $61,708,071
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$STE Congressional Stock Trading
Members of Congress have traded $STE stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $STE stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 3 times. They made 2 purchases worth up to $30,000 on 09/18, 09/11 and 1 sale worth up to $15,000 on 06/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$STE Analyst Ratings
Wall Street analysts have issued reports on $STE in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 08/08/2025
- JMP Securities issued a "Market Outperform" rating on 05/16/2025
- Stephens & Co. issued a "Overweight" rating on 05/15/2025
To track analyst ratings and price targets for $STE, check out Quiver Quantitative's $STE forecast page.
$STE Price Targets
Multiple analysts have issued price targets for $STE recently. We have seen 5 analysts offer price targets for $STE in the last 6 months, with a median target of $280.0.
Here are some recent targets:
- Patrick Wood from Morgan Stanley set a target price of $295.0 on 08/08/2025
- Brett Fishbin from Keybanc set a target price of $288.0 on 07/22/2025
- David Windley from Jefferies set a target price of $263.0 on 05/29/2025
- David Turkaly from JMP Securities set a target price of $280.0 on 05/16/2025
- Steven Etoch from Stephens & Co. set a target price of $250.0 on 05/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
